Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adeno-associated virus-mediated gene therapy in cardiovascular disease

18 Mar 2015

Abstract excerpt

PURPOSE OF REVIEW: The use of adeno-associated virus (AAV) as an efficient, cardiotropic, and safe vector, coupled with the identification of key molecular targets, has placed gene-based therapies within reach of cardiovascular diseases. The purpose of this review is to provide a focused update on the current advances related to AAV-mediated gene therapy in cardiovascular diseases, and particularly in heart...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25783685
DOI: 10.1097/hco.0000000000000159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adeno-associated virus-mediated gene therapy in cardiovascular diseasePMID 25783685Read ↗

Cardiac gene therapy with adeno-associated virus-based vectorsSemantic proximity Read ↗

AAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical OpportunitiesSemantic proximity Read ↗

Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart FailureSemantic proximity Read ↗

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationSemantic proximity Read ↗

Sarcoplasmic reticulum Ca<sup>2+</sup>ATPase as a therapeutic target for heart failureSemantic proximity Read ↗

State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSemantic proximity Read ↗

An Emerging Adeno-Associated Viral Vector Pipeline for Cardiac Gene TherapySemantic proximity Read ↗

Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular SystemSemantic proximity Read ↗

The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical PerspectiveSemantic proximity Read ↗

Gene therapy for the treatment of heart failure: promise postponedSemantic proximity Read ↗

Molecular targets in heart failure gene therapy: current controversies and translational perspectivesSemantic proximity Read ↗

Targeting the heart with gene therapy-optimized gene delivery methodsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.